Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F9GT5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,522
Award facts
- Contract value 100% obligated
- $26,522.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls with a ceiling value of $26,522.17 and a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of December 22, 2025, and will be fulfilled from the company's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement designated SPE2DX that extends through December 2026 and serves as the primary pharmaceutical supply vehicle for military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a substantial portfolio of federal medical supply contracts with the Defense Logistics Agency, demonstrating proven capability to meet competitive procurement requirements across multiple therapeutic domains. The company supplies an extensive range of products including brand-name and generic medications, vaccines, and specialized medical supplies to support military and veteran healthcare systems. This delivery order for HUMIRA, a biologic immunosuppressant medication, exemplifies the company's role as a critical vendor within the DLA Medical Supply Chain, fulfilling pharmaceutical needs for the Defense Health Agency and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F9GT5?
SPE2DR26F9GT5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F9GT5 worth?
The government has obligated $26,522 on SPE2DR26F9GT5.
Is contract SPE2DR26F9GT5 an order under another contract?
Yes. SPE2DR26F9GT5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GT5 competed?
The extent of competition for SPE2DR26F9GT5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award